Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-23T14:33:52.151Z Has data issue: false hasContentIssue false
  • English
  • Français

Personal experience with clozapine

Published online by Cambridge University Press:  02 January 2018

Michael A. Launer
Michael A. Launer*
Affiliation:
Burnley General Hospital Lamont Clinic Burnley BB10 2PQ
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
Psychiatric Bulletin , Volume 15 , Issue 4 , April 1991 , pp. 223 - 224
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1991

References

Griffith, R. W. & Saameli, K. (1990) Clozapine and agranulocytosis. Lancet, ii, 657.Google Scholar
Kane, J., Honigfeld, G., Singer, J. & Meltzer, H. (1988) Clozapine for the treatment resistant schizophrenic. A double blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789–796.CrossRefGoogle ScholarPubMed
Naber, D., Leppig, M., Grohmann, R. & Hippius, H. (1989) Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia – a retrospective study. Psychopharmacology, 99, S73–S76.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.